ArticleLife (Basel, Switzerland)2026
Fullerol Attenuates Diabetic Muscle Atrophy and Ferroptosis-Associated Injury: Intervention Timing Influences Myogenesis-Associated Responses In Vitro.
Article in Life (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Glucolipotoxic stress contributes to diabetic muscle atrophy by disrupting myoblast homeostasis and myogenesis-associated responses. Fullerol is a water-soluble polyhydroxylated fullerene derivative with potent free-radical-scavenging activity. We investigated the protective effects of fullerol and compared concurrent and post-HGPA intervention schedules in C2C12 myoblasts. We evaluated C2C12 myoblasts exposed to high glucose plus palmitic acid (HGPA), RAW264.7 macrophages, macrophage-conditioned medium, and male C57BL/6J mice subjected to a high-fat diet (HFD) and streptozotocin (STZ). In the animal experiment, fullerol was administered locally during diabetic model development, whereas intervention timing was compared only in the C2C12 model. In myoblasts, HGPA induced Fe
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.